J. Kazama

发表

Adsorption of Protein‐Bound Uremic Toxins Through Direct Hemoperfusion With Hexadecyl‐Immobilized Cellulose Beads in Patients Undergoing Hemodialysis

S. Goto, I. Narita, F. Gejyo, 2018, Artificial organs.

Expression of Tight Junction Protein Claudin-1 in Human Crescentic Glomerulonephritis

I. Narita, Y. Ueda, J. Kazama, 2014, International journal of nephrology.

Molecular Abnormalities Underlying Bone Fragility in Chronic Kidney Disease

M. Fukagawa, J. Kazama, Y. Iwasaki, 2017, BioMed research international.

Hyporesponsiveness to long-acting erythropoiesis-stimulating agent is related to the risk of cardiovascular disease and death in Japanese patients on chronic hemodialysis: observational cohort study

Shuhei Watanabe, J. Kazama, Yoshihiro Tani, 2021, Renal Replacement Therapy.

Continuous Reduction of Protein-Bound Uraemic Toxins with Improved Oxidative Stress by Using the Oral Charcoal Adsorbent AST-120 in Haemodialysis Patients

I. Narita, T. Maruyama, Hiroshi Watanabe, 2015, Scientific Reports.

Removal of uremic toxins by renal replacement therapies: a review of current progress and future perspectives

S. Goto, I. Narita, Suguru Yamamoto, 2016, Renal Replacement Therapy.

Possible involvement of circulating fibroblast growth factor 23 in the development of secondary hyperparathyroidism associated with renal insufficiency.

T. Shigematsu, T. Hosoya, F. Gejyo, 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.

A Case Report of Severe Visceral β2‐Microglobulin‐derived Amyloidosis Without Obvious Joint Symptoms or Radiological Findings in a Chronic Hemodialyzed Patient With Systemic Lupus Erythematosus

I. Narita, F. Gejyo, Tomoyuki Ito, 2009, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

131I-beta 2-microglobulin scintigraphy in patients with dialysis amyloidosis.

F. Gejyo, M. Arakawa, I. Odano, 1995, Clinical nephrology.

Higher Mortality Due to Intracerebral Hemorrhage in Dialysis Patients: A Comparison with the General Population in Japan

I. Narita, J. Kazama, M. Wakasugi, 2015, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

Type I Angiotensin II Receptor Blockade Reduces Uremia‐Induced Deterioration of Bone Material Properties

S. Fukuhara, S. Goto, I. Narita, 2020, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Altered material properties are responsible for bone fragility in rats with chronic kidney injury.

Aira Matsugaki, T. Nakano, M. Fukagawa, 2015, Bone.

VI. Chronic Kidney Disease and Fragility Fracture

J. Kazama, 2015 .

Uremic osteoporosis

M. Fukagawa, J. Kazama, Y. Iwasaki, 2013, Kidney international supplements.

Cancellous bone volume is an indicator for trabecular bone connectivity in dialysis patients.

I. Narita, F. Gejyo, Suguru Yamamoto, 2010, Clinical journal of the American Society of Nephrology : CJASN.

Comparison of Quantitative Cancellous Bone Connectivity Analyses at Two- and Three-Dimensional Levels in Dialysis Patients

I. Narita, F. Gejyo, Suguru Yamamoto, 2008, Calcified Tissue International.

Xanthine oxidase inhibitors are associated with reduced risk of cardiovascular disease

Shuhei Watanabe, M. Shimabukuro, J. Kazama, 2021, Scientific reports.

Associations between Dietary Patterns and Cardiometabolic Risks in Japan: A Cross-Sectional Study from the Fukushima Health Management Survey, 2011–2015

S. Yasumura, E. Ma, H. Yabe, 2020, Nutrients.

A combination of healthy lifestyle factors is associated with a decreased incidence of chronic kidney disease: a population-based cohort study

I. Narita, Suguru Yamamoto, J. Kazama, 2013, Hypertension Research.

Relationship between the prevalence of polycythemia and factors observed in the mental health and lifestyle survey after the Great East Japan Earthquake

M. Hosoya, S. Yasumura, Y. Kawasaki, 2020, Medicine.

Age- and gender-specific incidence rates of renal replacement therapy in Japan: an international comparison

I. Narita, J. Kazama, M. Wakasugi, 2016, Renal Replacement Therapy.

Association between Serum Inorganic Phosphorus Levels and Adverse Outcomes in Chronic Kidney Disease: The Fukushima CKD Cohort Study

Shuhei Watanabe, J. Kazama, K. Asahi, 2021, Internal medicine.

Indoxyl Sulfate Promotes Macrophage IL-1β Production by Activating Aryl Hydrocarbon Receptor/NF-κ/MAPK Cascades, but the NLRP3 inflammasome Was Not Activated

S. Goto, I. Narita, F. Gejyo, 2018, Toxins.

Relationship between Xanthine Oxidoreductase Redox and Oxidative Stress among Chronic Kidney Disease Patients

J. Kazama, S. Uchida, T. Murase, 2018, Oxidative medicine and cellular longevity.

The Relationship between Xanthine Oxidoreductase and Xanthine Oxidase Activities in Plasma and Kidney Dysfunction

J. Kazama, T. Murase, Takashi Nakamura, 2017 .

Anticipated Increase in the Number of Patients Who Require Dialysis Treatment Among the Aging Population of Japan

Increased Proinflammatory Cytokine Production and Decreased Cholesterol Efflux Due to Downregulation of ABCG1 in Macrophages Exposed to Indoxyl Sulfate

S. Goto, I. Narita, Suguru Yamamoto, 2015, Toxins.

Use of Japanese Society for Dialysis Therapy Dialysis Tables to Compare the Local and National Incidence of Dialysis

I. Narita, J. Kazama, M. Wakasugi, 2012, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

An Overview of Regular Dialysis Treatment in Japan (as of 31 December 2012)

T. Hasegawa, K. Wakai, K. Iseki, 2014, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

Overview of Regular Dialysis Treatment in Japan (as of 31 December 2009)

T. Hasegawa, K. Wakai, K. Iseki, 2012, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

Association between serum potassium levels and adverse outcomes in chronic kidney disease: the Fukushima CKD cohort study

Shuhei Watanabe, M. Shimabukuro, J. Kazama, 2021, Clinical and Experimental Nephrology.

Serum cystatin C measured by a sol particle homogeneous immunoassay can accurately detect early impairment of renal function

I. Narita, F. Gejyo, J. Kazama, 2008, Clinical and Experimental Nephrology.

Regional variations in immunosuppressive therapy in patients with primary nephrotic syndrome: the Japan nephrotic syndrome cohort study

Yusuke Suzuki, I. Narita, T. Nishino, 2018, Clinical and Experimental Nephrology.

Clinical Practice Guideline for the Management of Chronic Kidney Disease‐Mineral and Bone Disorder

K. Iseki, N. Fujii, T. Shigematsu, 2013, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

Blood pressure control in chronic kidney disease according to underlying renal disease: the Fukushima CKD cohort

M. Shimabukuro, J. Kazama, K. Asahi, 2019, Clinical and Experimental Nephrology.

The Risk of Gallbladder Stone Formation Is Increased in Patients with Predialysis Chronic Kidney Disease but Not Those Undergoing Chronic Hemodialysis Therapy

I. Narita, F. Gejyo, Suguru Yamamoto, 2009, Nephron Clinical Practice.

Use of Renin-Angiotensin System Inhibitors Is Associated with Reduction of Fracture Risk in Hemodialysis Patients

S. Fukuhara, I. Narita, T. Akizawa, 2015, PloS one.

The making of a bone in blood vessels: from the soft shell to the hard bone.

M. Fukagawa, J. Kazama, 2007, Kidney international.

Hemodiafiltration for hepatic encephalopathy induced by Budd–Chiari syndrome in a patient with end-stage kidney disease

S. Goto, I. Narita, K. Kamimura, 2016, CEN Case Reports.

Rosuvastatin pretreatment suppresses distant organ injury following unilateral renal ischemia‐reperfusion in hypertensive Dahl salt‐sensitive rats

Wanjun Zhu, M. Nakayama, J. Kazama, 2018, Nephrology.

The cumulative incidence of and risk factors for latent beaking in patients with autoimmune diseases taking long-term glucocorticoids and bisphosphonates

I. Narita, N. Endo, J. Kazama, 2016, Osteoporosis International.

Burden of Undiagnosed Type 2 Diabetes in Diabetic Kidney Disease: A Japanese Retrospective Cohort Study

M. Shimabukuro, J. Kazama, K. Asahi, 2020, Journal of clinical medicine.

Clinical and cardiac features of patients with subarachnoid haemorrhage presenting with out-of-hospital cardiac arrest.

Masahiro Ito, M. Tomita, M. Kodama, 2011, Resuscitation.

Dialysis disequilibrium syndrome induced by neoplastic meningitis in a patient receiving maintenance hemodialysis

I. Narita, J. Kazama, T. Ikarashi, 2013, BMC Nephrology.

Predictors of early remission of proteinuria in adult patients with minimal change disease: a retrospective cohort study

Yusuke Suzuki, Mina Kato, Tsutomu Inoue, 2022, Scientific Reports.

Time to remission of proteinuria and incidence of relapse in patients with steroid-sensitive minimal change disease and focal segmental glomerulosclerosis: the Japan Nephrotic Syndrome Cohort Study

Yusuke Suzuki, Mina Kato, Tsutomu Inoue, 2022, Journal of Nephrology.

Dietary Patterns and Progression of Impaired Kidney Function in Japanese Adults: A Longitudinal Analysis for the Fukushima Health Management Survey, 2011–2015

M. Hosoya, S. Yasumura, E. Ma, 2021, Nutrients.

Suboptimal diabetic control and psychological burden after the triple disaster in Japan: the Fukushima Health Management Survey

M. Hosoya, S. Yasumura, H. Ohira, 2021, BMJ Open Diabetes Research & Care.

Clinical and histological features in pediatric and adolescent/young adult patients with renal disease: a cross-sectional analysis of the Japan Renal Biopsy Registry (J-RBR)

A. Nakashima, Yusuke Suzuki, Tetsuhiro Tanaka, 2021, Clinical and Experimental Nephrology.

High FIB4 index is an independent risk factor of diabetic kidney disease in type 2 diabetes

K. Abe, H. Ohira, M. Shimabukuro, 2021, Scientific Reports.

Better remission rates in elderly Japanese patients with primary membranous nephropathy in nationwide real-world practice: The Japan Nephrotic Syndrome Cohort Study (JNSCS)

Yusuke Suzuki, I. Narita, T. Nishino, 2020, Clinical and Experimental Nephrology.

Serum hepcidin level, iron metabolism and osteoporosis in patients with rheumatoid arthritis

H. Ishikawa, S. Ito, I. Narita, 2020, Scientific Reports.

Incidence of remission and relapse of proteinuria, end-stage kidney disease, mortality, and major outcomes in primary nephrotic syndrome: the Japan Nephrotic Syndrome Cohort Study (JNSCS)

Yusuke Suzuki, I. Narita, T. Nishino, 2020, Clinical and Experimental Nephrology.

Utility of estimated glomerular filtration rate using cystatin C and its interpretation in patients with rheumatoid arthritis under glucocorticoid therapy.

I. Narita, J. Kazama, Y. Wada, 2018, Clinica chimica acta; international journal of clinical chemistry.

The impact of evacuation on the incidence of chronic kidney disease after the Great East Japan Earthquake: The Fukushima Health Management Survey

M. Nagai, M. Hosoya, S. Yasumura, 2017, Clinical and Experimental Nephrology.

Serum Fibroblast Growth Factor 23 (FGF23) in Patients with Rheumatoid Arthritis.

H. Ishikawa, A. Murasawa, S. Ito, 2016, Internal medicine.

A Case of Membranous Glomerulonephropathy Associated with Takayasu's Arteritis

I. Narita, Y. Ueda, J. Kazama, 2014, Case Reports in Nephrology and Dialysis.

Decreased levels of circulating alpha2-Heremans-Schmid glycoprotein/Fetuin-A (AHSG) in patients with rheumatoid arthritis.

I. Narita, F. Gejyo, J. Kazama, 2007, Internal medicine.

Relationship Between Risk of Hyper-Low-density Lipoprotein Cholesterolemia and Evacuation After the Great East Japan Earthquake

M. Hosoya, S. Yasumura, Y. Kawasaki, 2021, Journal of epidemiology.

Vitamin D Receptor Activator Use and Cause-specific Death among dialysis Patients: a Nationwide Cohort Study using Coarsened Exact Matching

K. Wakai, K. Iseki, S. Nakai, 2017, Scientific Reports.

Pharmacokinetics of paclitaxel and cisplatin in a hemodialysis patient with recurrent ovarian cancer

Kenichi Tanaka, M. Tomita, Y. Aoki, 2001, Anti-cancer drugs.

Nuclear Chromatin‐concentrated Osteoblasts in Renal Bone Diseases

I. Narita, Suguru Yamamoto, J. Kazama, 2011, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

Bone Histology in Chronic Kidney Disease‐related Mineral and Bone Disorder

J. Kazama, 2011, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

Circulating Osteoprotegerin Affects Bone Metabolism in Dialysis Patients With Mild Secondary Hyperparathyroidism

I. Narita, Yumi Ito, F. Gejyo, 2006, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

24R, 25‐Dihydroxyvitamin D3 ameliorates the high‐turnover bone diseases without suppressing parathyroid function in chronic renal failure in rats

F. Gejyo, M. Arakawa, K. Kurokawa, 1996 .

Parathyroid Hormone and Bone in Dialysis Patients

J. Kazama, M. Wakasugi, 2018, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

Osteoprotegerin and bone mineral metabolism in renal failure

J. Kazama, 2004, Current opinion in nephrology and hypertension.

2018 annual dialysis data report of the JSDT Renal Data Registry: patients with hepatitis

T. Hasegawa, N. Hirawa, S. Nakai, 2021, Renal Replacement Therapy.

Association between warfarin use and incidence of ischemic stroke in Japanese hemodialysis patients with chronic sustained atrial fibrillation: a prospective cohort study

I. Narita, M. Kawachi, I. Ei, 2014, Clinical and Experimental Nephrology.

High Mortality Rate of Infectious Diseases in Dialysis Patients: A Comparison With the General Population in Japan

I. Narita, Suguru Yamamoto, J. Kazama, 2012, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

Cause‐Specific Excess Mortality Among Dialysis Patients: Comparison With the General Population in Japan

I. Narita, Suguru Yamamoto, J. Kazama, 2013, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

Evacuation after the Great East Japan Earthquake is an independent factor associated with hyperuricemia: The Fukushima Health Management Survey.

M. Hosoya, S. Yasumura, H. Ohira, 2021, Nutrition, metabolism, and cardiovascular diseases : NMCD.

Reduction of circulating β2‐microglobulin level for the treatment of dialysis‐related amyloidosis

F. Gejyo, J. Kazama, H. Maruyama, 2001 .

Bioengineered implantation of megalin-expressing cells: a potential intracorporeal therapeutic model for uremic toxin protein clearance in renal failure.

Y. Tabata, R. Orlando, F. Gejyo, 2003, Journal of the American Society of Nephrology : JASN.

Effects of Serum Calcium, Phosphorous, and Intact Parathyroid Hormone Levels on Survival in Chronic Hemodialysis Patients in Japan

K. Iseki, S. Nakai, T. Akiba, 2008, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

Chronic kidney disease and fragility fracture

J. Kazama, 2016, Clinical and Experimental Nephrology.

A higher serum alkaline phosphatase is associated with the incidence of hip fracture and mortality among patients receiving hemodialysis in Japan.

K. Iseki, T. Yokoo, T. Shigematsu, 2014, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Chronic kidney disease and bone metabolism

M. Fukagawa, J. Kazama, Y. Iwasaki, 2015, Journal of Bone and Mineral Metabolism.

Oral phosphate binders: history and prospects.

J. Kazama, 2009, Bone.

Japanese Society of Dialysis Therapy Treatment Guidelines for Secondary Hyperparathyroidism

J. Kazama, 2007, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

FGF23: its role in renal bone disease

M. Fukagawa, J. Kazama, 2006, Pediatric Nephrology.

With or without the kidney: the role of FGF23 in CKD.

M. Fukagawa, J. Kazama, 2005, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Basic and clinical aspects of parathyroid hyperplasia in chronic kidney disease.

M. Fukagawa, J. Kazama, S. Nakanishi, 2006, Kidney international. Supplement.

Direct Comparison between Two 1-84PTH Assays in Dialysis Patients

I. Narita, T. Shigematsu, F. Gejyo, 2005, Nephron Clinical Practice.

Histocytochemical study of Spot 35‐calbindin‐D28K and Ca2+‐ATPase in rat kidney

R. Kuwano, T. Kumanishi, M. Arakawa, 1995 .

Evidence indicating that renal tubular metabolism of leptin is mediated by megalin but not by the leptin receptors.

F. Gejyo, J. Kazama, A. Saito, 2004, Endocrinology.

Lifestyle Factors Associated With Undernutrition in Older People After the Great East Japan Earthquake. A Prospective Study

S. Yasumura, T. Ohira, M. Shimabukuro, 2020 .

Novel insights into parathyroid hormone: report of The Parathyroid Day in Chronic Kidney Disease

E. Hindié, M. Vervloet, Z. Massy, 2018, Clinical kidney journal.

Cumulative incidence of femoral localized periosteal thickening (beaking) preceding atypical femoral fractures in patients with rheumatoid arthritis

H. Ishikawa, S. Ito, I. Narita, 2020, Osteoporosis International.

Adsorption of Protein-Bound Uremic Toxins Using Activated Carbon through Direct Hemoperfusion in vitro

S. Goto, I. Narita, F. Gejyo, 2019, Blood Purification.

Administration of Ferric Citrate Hydrate Decreases Circulating FGF23 Levels Independently of Serum Phosphate Levels in Hemodialysis Patients with Iron Deficiency

I. Narita, Suguru Yamamoto, Akira Iguchi, 2015, Nephron.

Increased circulating levels of osteoclastogenesis inhibitory factor (osteoprotegerin) in patients with chronic renal failure.

T. Shigematsu, Y. Kawaguchi, F. Gejyo, 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Total parathyroidectomy reduces elevated circulating fibroblast growth factor 23 in advanced secondary hyperparathyroidism.

N. Goto, F. Gejyo, M. Fukagawa, 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Sevelamer Hydrochloride and Calcium Bicarbonate Reduce Serum Fibroblast Growth Factor 23 Levels in Dialysis Patients

T. Shigematsu, M. Fukagawa, J. Kazama, 2005, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

The Association between Earlobe Creases and Cardiovascular Events in Japanese Hemodialysis Patients: A Prospective Cohort Study

I. Narita, K. Omori, J. Kazama, 2019, Internal medicine.

Effect of ferric citrate hydrate on FGF23 and PTH levels in patients with non-dialysis-dependent chronic kidney disease with normophosphatemia and iron deficiency

I. Narita, Suguru Yamamoto, Akira Iguchi, 2018, Clinical and Experimental Nephrology.

Th17 Cells Participate in Thy1.1 Glomerulonephritis Which Is Ameliorated by Tacrolimus

H. Kawachi, J. Kazama, Y. Fukusumi, 2022, American Journal of Nephrology.

Management of patients with advanced secondary hyperparathyroidism: the Japanese approach.

T. Shigematsu, M. Fukagawa, J. Kazama, 2002, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

What does the circulating AHSG/fetuin-A level tell us?

J. Kazama, 2007, Clinical and Experimental Nephrology.

Effects of a novel elastase inhibitor, ONO-5046, on nephrotoxic serum nephritis in rats.

F. Gejyo, M. Arakawa, J. Kazama, 1998, Kidney international.

Role of fibroblast growth factor 23 in health and in chronic kidney disease

M. Fukagawa, J. Kazama, T. Nii-Kono, 2005, Current opinion in nephrology and hypertension.

Fibroblast growth factor (FGF)-23 in patients with primary hyperparathyroidism.

T. Shigematsu, T. Shimada, S. Fukumoto, 2004, European journal of endocrinology.

Fibroblast growth factor-23 in patients with Graves' disease before and after antithyroid therapy: its important role in serum phosphate regulation.

T. Shigematsu, S. Fukumoto, M. Fukagawa, 2005, The Journal of clinical endocrinology and metabolism.

Hematological parameters of anemia and prognosis of non-dialysis-dependent chronic kidney disease: the Fukushima CKD cohort study

Shuhei Watanabe, J. Kazama, K. Asahi, 2022, Clinical and Experimental Nephrology.

Fibroblast growth factor-23 (FGF23) in patients with transient hypoparathyroidism: its important role in serum phosphate regulation.

T. Shigematsu, S. Fukumoto, M. Fukagawa, 2007, Endocrine journal.

Etiology and prognostic significance of severe uremic pruritus in chronic hemodialysis patients.

K. Akazawa, I. Narita, S. Maruyama, 2006, Kidney international.

Osteoprotegerin levels before and after renal transplantation.

T. Shigematsu, J. Kazama, T. Haba, 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Alterations in serum phosphate levels predict the long-term response to intravenous calcitriol therapy in dialysis patients with secondary hyperparathyroidism

I. Narita, Yumi Ito, F. Gejyo, 2008, Journal of Bone and Mineral Metabolism.

Disrupted tubular parathyroid hormone/parathyroid hormone receptor signaling and damaged tubular cell viability possibly trigger postsurgical kidney injury in patients with advanced hyperparathyroidism

Y. Kikkawa, M. Fukagawa, Suguru Yamamoto, 2019, Clinical kidney journal.

Eye diseases in women.

N. Ando, J. Kazama, Sakumi Kazama, 2019, Fukushima journal of medical science.

Effect of sucroferric oxyhydroxide on gastrointestinal microbiome and uremic toxins in patients with chronic kidney disease undergoing hemodialysis

I. Narita, T. Suzutani, Suguru Yamamoto, 2020, Clinical and Experimental Nephrology.

Ectopic Calcification as Abnormal Biomineralization

N. Amizuka, M. Fukagawa, J. Kazama, 2006 .

Aβ-2M-amyloidosis and related bone diseases

I. Narita, Yumi Ito, F. Gejyo, 2006, Journal of Bone and Mineral Metabolism.

A patient with severe hypercalcemia in multiple organ dysfunction syndrome: Role of elevated circulating 1α,25(OH)2vitamin D levels

Yoshinobu Sato, I. Narita, Satoshi Yamamoto, 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Autophagy: a two-edged sword in diabetes mellitus.

M. Fukagawa, Suguru Yamamoto, J. Kazama, 2013, The Biochemical journal.

In and out of the bone: can the osteocyte escape skeletal jail and yet regulate mineralization?

M. Fukagawa, J. Kazama, 2014, Kidney International.

Association between Dietary Diversity and Sociopsychological Factors and the Onset of Dyslipidemia after the Great East Japan Earthquake: Fukushima Health Management Survey

M. Hosoya, S. Yasumura, H. Yabe, 2022, International journal of environmental research and public health.

K. Iseki, I. Narita, Y. Shibagaki, 2022, Scientific Reports.

Long-term excess mortality after hip fracture in hemodialysis patients: a nationwide cohort study in Japan

I. Narita, T. Hamano, J. Kazama, 2020, Journal of Bone and Mineral Metabolism.

Atazanavir : a novel inhibitor of HIV-protease in haemodialysis

I. Ei, J. Kazama, 2005 .

Reflex Anuria Following Retrograde Pyelography: A Case Report and Literature Review

J. Kazama, Makoto Kanno, Kenichi Tanaka, 2019, Internal medicine.

Functional impairment attenuates the association between high serum phosphate and mortality in dialysis patients: a nationwide cohort study.

I. Narita, T. Hamano, J. Kazama, 2018, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Persistent metabolic acidosis in a hemodialyzed patient with short bowel syndrome.

I. Narita, J. Kazama, R. Koda, 2013, Internal medicine.

Comparison between Whole and Intact Parathyroid Hormone Assays

T. Shigematsu, T. Akiba, H. Fujii, 2011, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

Circulating 1-84 PTH and large C-terminal PTH fragment levels in uremia

I. Narita, T. Shigematsu, F. Gejyo, 2003, Journal of Clinical and Experimental Nephrology.

Skeletal resistance to pth as a basic abnormality underlying uremic bone diseases.

T. Shigematsu, M. Fukagawa, J. Kazama, 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Comparison of intact PTH assay and whole PTH assay in long-term dialysis patients.

T. Shigematsu, J. Kazama, S. Nakanishi, 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Dietary Patterns and New-Onset Type 2 Diabetes Mellitus in Evacuees after the Great East Japan Earthquake: A 7-Year Longitudinal Analysis in the Fukushima Health Management Survey

S. Yasumura, E. Ma, H. Yabe, 2022, Nutrients.

Role of Circulating Fibroblast Growth Factor 23 in the Development of Secondary Hyperparathyroidism

T. Shigematsu, F. Gejyo, M. Fukagawa, 2005, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

Association between serum phosphorus levels and adverse outcomes in chronic kidney disease: an observational cohort study

Shuhei Watanabe, M. Shimabukuro, J. Kazama, 2021 .

First-in-Patient Phase I/II Study of Upacicalcet in Japanese Patients with Secondary Hyperparathyroidism Undergoing Hemodialysis: Pharmacokinetic and Pharmacodynamic Properties

K. Asano, T. Akizawa, M. Fukagawa, 2022, Clinical Pharmacokinetics.

High-fat diet in low-dose-streptozotocin-treated heminephrectomized rats induces all features of human type 2 diabetic nephropathy: a new rat model of diabetic nephropathy.

J. Kazama, H. Yamato, Mikio Sugano, 2006, Nutrition, metabolism, and cardiovascular diseases : NMCD.

High and pointed type of femoral localized reaction frequently extends to complete and incomplete atypical femoral fracture in patients with autoimmune diseases on long-term glucocorticoids and bisphosphonates

I. Narita, N. Endo, J. Kazama, 2017, Osteoporosis International.

Suction towards a vessel wall by hemodialysis catheters—the establishment of a new experimental extracorporeal circulation system using pig veins

T. Oite, I. Narita, Suguru Yamamoto, 2018, Renal Replacement Therapy.

Intact PTH assay overestimates true 1-84 PTH levels after maxacalcitol therapy in dialysis patients with secondary hyperparathyroidism.

I. Narita, Yumi Ito, F. Gejyo, 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Para-capillary electron-dense deposits reduce glomerular filtration in patients with primary glomerular diseases

I. Narita, F. Gejyo, H. Mori, 2006, Clinical and Experimental Nephrology.

Hemodialysis Product and Hip Fracture in Hemodialysis Patients: A Nationwide Cohort Study in Japan

I. Narita, T. Hamano, J. Kazama, 2019, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

High rates of death and hospitalization follow bone fracture among hemodialysis patients.

I. Narita, J. Kazama, M. Wakasugi, 2014, Kidney international.

The relation between lactate clearance and 30 days mortality in patients with respiratory failure

T. Wakai, J. Kazama, H. Endoh, 2005 .

Combined Ala601-Thr-type dysplasminogenaemia and antiphospholipid antibody syndrome in a patient with recurrent thrombosis.

S. Ito, F. Gejyo, S. Nishi, 2002, Thrombosis research.

Recent progress in understanding dialysis-related amyloidosis.

I. Narita, F. Gejyo, H. Naiki, 2009, Bone.

Crowned Dens Syndrome as an Initial Manifestation of Crystalline Deposition Disease.

I. Narita, J. Kazama, R. Koda, 2015, Internal medicine.

Accumulated uremic toxins attenuate bone mechanical properties in rats with chronic kidney disease.

H. Shimoda, M. Fukagawa, J. Kazama, 2013, Bone.

High‐level expression of naked DNA delivered to rat liver via tail vein injection

J. Miyazaki, M. Sugawa, F. Gejyo, 2002, The journal of gene medicine.

Association of the MCP-1 gene polymorphism A-2518G with carpal-tunnel syndrome in hemodialysis patients

S. Goto, I. Narita, F. Gejyo, 2002, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

Serum fibroblast growth factor-23 levels predict the future refractory hyperparathyroidism in dialysis patients.

T. Shigematsu, F. Gejyo, S. Fukumoto, 2005, Kidney international.

Pretreatment serum FGF-23 levels predict the efficacy of calcitriol therapy in dialysis patients.

I. Narita, F. Gejyo, S. Fukumoto, 2005, Kidney international.

Prevalence of Earlobe Creases and Their Association With History of Cardiovascular Disease in Patients Undergoing Hemodialysis: A Cross‐Sectional Study

I. Narita, Suguru Yamamoto, K. Omori, 2017, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

Lenalidomide as a Beneficial Treatment Option for Renal Impairment Caused by Light Chain Deposition Disease

T. Ikezoe, K. Ikeda, T. Sano, 2018, Internal medicine.

Evidence for megalin-mediated proximal tubular uptake of L-FABP, a carrier of potentially nephrotoxic molecules

Tadashi Yamamoto, H. Fujii, Y. Terada, 2005, Laboratory Investigation.

Antibody and T-Cell Responses against SARS-CoV-2 after Booster Vaccination in Patients on Dialysis: A Prospective Observational Study

K. Shibuya, T. Sawano, M. Tsubokura, 2023, Vaccines.

Annual dialysis data report of the 2018 JSDT Renal Data Registry: dementia, performance status, and exercise habits

T. Hasegawa, N. Hirawa, S. Nakai, 2021, Renal Replacement Therapy.

Casein kinase 2 phosphorylation of recombinant rat osteopontin enhances adhesion of osteoclasts but not osteoblasts

T. Martin, C. House, J. Kazama, 1998, Journal of cellular physiology.

An Overview of Regular Dialysis Treatment in Japan (As of 31 December 2010)

Takayuki Hamano, Tetsuo Shoji, Hidetomo Nakamoto, 2012, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

Factors Associated with Risk of Diabetic Complications in Novel Cluster-Based Diabetes Subgroups: A Japanese Retrospective Cohort Study

M. Shimabukuro, H. Masuzaki, J. Kazama, 2020, Journal of clinical medicine.

A case of late onset primary hyperoxaluria type I (PH-I) presented with black liver.

A. Terano, J. Kazama, H. Sugaya, 1998, Clinical nephrology.

Serum Cystatin C Reliably Detects Renal Dysfunction in Patients with Various Renal Diseases

F. Gejyo, J. Kazama, H. Maruyama, 2002, Nephron.

Acute tubulointerstitial nephritis with multiple organ involvement including fatal adrenalitis: a case report with autopsy findings.

I. Narita, S. Miyazaki, J. Kazama, 2012, Internal medicine.

Relationship between physical activity/exercise habits and the frequency of new onset of lifestyle-related diseases after the Great East Japan Earthquake among residents in Fukushima: the Fukushima Health Management Survey

M. Hosoya, S. Yasumura, Y. Kawasaki, 2021, Journal of radiation research.

Hip Fracture Trends in Japanese Dialysis Patients, 2008-2013.

I. Narita, T. Hamano, J. Kazama, 2017, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Pretreatment plasma intact parathyroid hormone and serum calcium levels, but not serum phosphate levels, predict the response to maxacalcitol therapy in dialysis patients with secondary hyperparathyroidism

I. Narita, Yumi Ito, F. Gejyo, 2005, Clinical and Experimental Nephrology.

Premature mortality due to nephrotic syndrome and the trend in nephrotic syndrome mortality in Japan, 1995–2014

I. Narita, J. Kazama, M. Wakasugi, 2018, Clinical and Experimental Nephrology.

Serum magnesium concentration is inversely associated with fibroblast growth factor 23 in haemodialysis patients

I. Narita, Akira Iguchi, J. Kazama, 2014, Nephrology.

Overview of Regular Dialysis Treatment in Japan (as of 31 December 2011)

Takayuki Hamano, Tetsuo Shoji, Hidetomo Nakamoto, 2013, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

Patients undergoing dialysis therapy for 30 years or more survive with serious osteoarticular disorders.

I. Narita, F. Gejyo, Suguru Yamamoto, 2008, Clinical nephrology.

Microfocus Computed Tomography Analysis of Early Changes in Bone Microstructure in Rats with Chronic Renal Failure

F. Gejyo, J. Kazama, H. Yamato, 2003, Nephron Experimental Nephrology.

Alfacalcidol Therapy Biphasically Modifies the Relationship between the Plasma Levels of Intact PTH and Osteocalcin in Dialysis Patients

J. Kazama, H. Takamiya, 1998, Nephron.

Pathophysiology of gastric acid secretion in patients with chronic renal failure: influence of Helicobacter pylori infection

A. Terano, H. Hiraishi, J. Kazama, 2003, Journal of internal medicine.

Association between Hypouricemia and Reduced Kidney Function: A Cross-Sectional Population-Based Study in Japan

Y. Ohashi, K. Iseki, I. Narita, 2015, American Journal of Nephrology.

Acute Kidney Injury and Remission of Proteinuria in Minimal Change Disease

I. Narita, T. Nishino, S. Nishio, 2022, Kidney international reports.

Osteoclastogenesis and osteoclast activation in dialysis-related amyloid osteopathy.

F. Gejyo, J. Kazama, H. Maruyama, 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Serum hepcidin level, iron metabolism and osteoporosis in patients with rheumatoid arthritis

H. Ishikawa, S. Ito, I. Narita, 2020, Scientific Reports.

Effects of External Radiation Exposure Resulting From the Fukushima Daiichi Nuclear Power Plant Accident on the Health of Residents in the Evacuation Zones: the Fukushima Health Management Survey

M. Hosoya, S. Yasumura, T. Ohira, 2022, Journal of epidemiology.

Psychological burden predicts new-onset diabetes in men: A longitudinal observational study in the Fukushima Health Management Survey after the Great East Japan earthquake

M. Hosoya, S. Yasumura, H. Yabe, 2022, Frontiers in Endocrinology.

Trends in Lifestyle-related Diseases and Their Risk Factors After the Fukushima Daiichi Nuclear Power Plant Accident: Results of the Comprehensive Health Check in the Fukushima Health Management Survey

M. Hosoya, S. Yasumura, Y. Kawasaki, 2022, Journal of epidemiology.

Transient left ventricular apical ballooning in a patient with cardiac arrest after subarachnoid hemorrhage.

M. Tomita, M. Kodama, Y. Aizawa, 2011, Journal of cardiology cases.

Increased risk of hip fracture among Japanese hemodialysis patients

K. Iseki, I. Narita, J. Kazama, 2013, Journal of Bone and Mineral Metabolism.

A nutritional assessment tool, GNRI, predicts sarcopenia and its components in type 2 diabetes mellitus: A Japanese cross-sectional study

H. Masuzaki, J. Kazama, Mizuki Yamaguchi, 2023, Frontiers in Nutrition.

Detecting Sarcopenia Risk by Diabetes Clustering: A Japanese Prospective Cohort Study.

H. Masuzaki, J. Kazama, H. Hirai, 2022, The Journal of clinical endocrinology and metabolism.

Association between height loss and mortality in the general population

K. Iseki, I. Narita, Y. Shibagaki, 2023, Scientific Reports.

Short-term use of continuous positive airway pressure ameliorates glomerular hyperfiltration in patients with obstructive sleep apnoea syndrome.

I. Narita, F. Gejyo, E. Suzuki, 2004, Clinical science.

Humoral response to SARS-CoV-2 vaccination in haemodialysis patients and a matched cohort

K. Shibuya, M. Tsubokura, M. Takita, 2022, BMJ Open.

Secular trends in end‐stage kidney disease requiring renal replacement therapy in Japan: Japanese Society of Dialysis Therapy Registry data from 1983 to 2016

I. Narita, J. Kazama, M. Wakasugi, 2020, Nephrology.

Advanced thymic cancer treated with carboplatin and paclitaxel in a patient undergoing hemodialysis.

S. Goto, I. Narita, Takehito Sakai, 2015, Internal medicine.

Continuous erythropoietin delivery by muscle-targeted gene transfer using in vivo electroporation.

J. Miyazaki, Y. Ishikawa, M. Sugawa, 2000, Human gene therapy.

Mortality trends among Japanese dialysis patients, 1988-2013: a joinpoint regression analysis.

I. Narita, J. Kazama, M. Wakasugi, 2016, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Changes in chemical composition of cortical bone associated with bone fragility in rat model with chronic kidney disease.

M. Fukagawa, J. Kazama, H. Yamato, 2011, Bone.

Clinical value of 99mTc-MIBI scintigraphy in patients with secondary hyperparathyroidism. A systematic review and meta-analysis of observational studies in Japan

I. Narita, J. Kazama, M. Wakasugi, 2011 .

Emotional disturbance assessed by the Self-Rating Depression Scale test is associated with mortality among Japanese Hemodialysis patients.

I. Narita, Yumi Ito, Motoko Tanaka, 2018, Fukushima journal of medical science.

Is IgA Nephropathy (IgAN) a Familial or Sporadic Disease

S. Goto, I. Narita, Suguru Yamamoto, 2016 .

Mortality predictors after 10 years of dialysis: a prospective study of Japanese hemodialysis patients.

K. Akazawa, I. Narita, F. Gejyo, 2007, Clinical journal of the American Society of Nephrology : CJASN.

Lower trabecular bone score is associated with an increased incidence of localized femoral periosteal thickening

I. Narita, N. Endo, J. Kazama, 2021, Journal of Bone and Mineral Metabolism.

Association of Polypharmacy with Kidney Disease Progression in Adults with CKD

Shuhei Watanabe, M. Shimabukuro, J. Kazama, 2021, Clinical journal of the American Society of Nephrology : CJASN.

Effects of Psychological and Lifestyle Factors on Metabolic Syndrome Following the Fukushima Daiichi Nuclear Power Plant Accident: The Fukushima Health Management Survey

M. Hosoya, S. Yasumura, Y. Kawasaki, 2020, Journal of atherosclerosis and thrombosis.

I. Narita, Suguru Yamamoto, J. Kazama, 2013 .

A hip fracture in a dialysis patient with Aβ2M amyloidosis.

I. Narita, Suguru Yamamoto, J. Kazama, 2014, Kidney international.

Effects of direct hemoperfusion with polymyxin B-immobilized fiber on rapidly progressive interstitial lung diseases.

I. Narita, E. Suzuki, J. Kazama, 2014, Internal medicine.

Peritoneal Dialysis Registry With 2012 Survey Report

T. Hasegawa, K. Wakai, K. Iseki, 2015, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

Association between Combined Lifestyle Factors and Non-Restorative Sleep in Japan: A Cross-Sectional Study Based on a Japanese Health Database

Y. Ohashi, K. Iseki, I. Narita, 2014, PloS one.

Circulating osteoprotegerin is not removed through haemodialysis membrane.

T. Shigematsu, F. Gejyo, M. Fukagawa, 2002, Nephrology, Dialysis and Transplantation.

Reduction of circulating beta2-microglobulin level for the treatment of dialysis-related amyloidosis.

F. Gejyo, J. Kazama, H. Maruyama, 2001, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Skeletal resistance to parathyroid hormone as a background abnormality in uremia

M. Fukagawa, J. Kazama, Y. Iwasaki, 2003, Nephrology.

Differences in the local and national prevalences of chronic kidney disease based on annual health check program data

I. Narita, J. Kazama, M. Wakasugi, 2012, Clinical and Experimental Nephrology.

Regional Variation in Hip Fracture Incidence Among Japanese Hemodialysis Patients

K. Iseki, I. Narita, J. Kazama, 2014, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

[Adynamic bone disease].

M. Fukagawa, J. Kazama, 2004, Nihon rinsho. Japanese journal of clinical medicine.

The Sequential Organ Failure Assessment Score as a Useful Predictor for Estimating the Prognosis of Systemic Inflammatory Response Syndrome Patients Being Treated with Extracorporeal Blood Purification

F. Gejyo, J. Kazama, H. Maruyama, 2003, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

Combined radioguided parathyroidectomy and intravenous vitamin D therapy for the treatment of uraemic hyperparathyroidism.

K. Hatakeyama, I. Narita, F. Gejyo, 2003, Nephrology, Dialysis and Transplantation.

[Fibroblast growth factor (FGF)-23 in patients with hypoparathyroidism].

T. Shigematsu, S. Fukumoto, M. Fukagawa, 2005, Clinical calcium.

The immunohistochemical localization of alpha2-Heremans-Schmid glycoprotein/fetuin-A (AHSG).

F. Gejyo, I. Ei, J. Kazama, 2005, Nephrology, Dialysis and Transplantation.

Initiation of renin–angiotensin system inhibitors and first complete remission in patients with primary nephrotic syndrome: a nationwide cohort study

Mina Kato, Tsutomu Inoue, S. Goto, 2023, Clinical and Experimental Nephrology.

[Renal bone disease and osteoprotegerin].

J. Kazama, 2003, Clinical calcium.

Effect of switching xanthine oxidoreductase inhibitor from febuxostat to topiroxostat on urinary protein excretion

J. Kazama, H. Terawaki, H. Hoshi, 2017, Clinical and Experimental Nephrology.

Clinical effects of a selective urate reabsorption inhibitor dotinurad in patients with hyperuricemia and treated hypertension: a multicenter, prospective, exploratory study (DIANA)

K. Yokoi, Masahiro Natsuaki, T. Wakatsuki, 2023, European Journal of Medical Research.

Association of polypharmacy with incidence of CKD: a retrospective cohort study

Shuhei Watanabe, J. Kazama, K. Asahi, 2022, Clinical and Experimental Nephrology.

Status of Anemia According to Underlying Renal Disease in Chronic Kidney Disease: The Fukushima CKD Cohort

Shuhei Watanabe, M. Shimabukuro, J. Kazama, 2021 .

Pathological findings of progressive renal involvement in a patient with TAFRO syndrome

M. Satoh, J. Kazama, Makoto Kanno, 2019, CEN Case Reports.

Impact of Lifestyle and Psychosocial Factors on the Incidence of Hepatobiliary Enzyme Abnormalities After the Great East Japan Earthquake: Seven-Year Follow-up of the Fukushima Health Management Survey

M. Hosoya, S. Yasumura, K. Hashimoto, 2023, Disaster Medicine and Public Health Preparedness.

Synovial inflammatory cells captured 131I-beta 2-microglobulin in patients with dialysis related amyloidosis.

F. Gejyo, M. Arakawa, J. Kazama, 1998, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

Role of macrophages in beta 2-microglobulin-related dialysis amyloidosis.

F. Gejyo, M. Arakawa, I. Ei, 1995, Contributions to Nephrology.

Association between Overall Lifestyle Changes and the Incidence of Proteinuria: A Population-based, Cohort Study

Y. Ohashi, K. Iseki, I. Narita, 2017, Internal medicine.

Changes in Metabolomic Profiles Induced by Switching from an Erythropoiesis-Stimulating Agent to a Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor in Hemodialysis Patients: A Pilot Study

Emiko Sato, M. Nakayama, J. Kazama, 2023, International journal of molecular sciences.

Impact of red blood cell distribution width–albumin ratio on prognosis of patients with CKD

J. Kazama, K. Asahi, H. Kimura, 2023, Scientific reports.

I. Narita, Suguru Yamamoto, J. Kazama, 2013 .

Intracerebral hemorrhage was the highest cause of mortality among stroke subtypes in Japanese dialysis patients

I. Narita, J. Kazama, M. Wakasugi, 2014, Hemodialysis international. International Symposium on Home Hemodialysis.

A patient with severe hypercalcemia in multiple organ dysfunction syndrome: Role of elevated circulating 1α,25(OH)2vitamin D levels

Yoshinobu Sato, I. Narita, Satoshi Yamamoto, 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Annual dialysis data report 2018, JSDT Renal Data Registry: dialysis fluid quality, hemodialysis and hemodiafiltration, peritoneal dialysis, and diabetes

T. Hasegawa, N. Hirawa, S. Nakai, 2020, Renal Replacement Therapy.

Accumulated uremic toxins attenuate bone mechanical properties in rats with chronic kidney disease.

H. Shimoda, M. Fukagawa, J. Kazama, 2013, Bone.

Abeta-2M-amyloidosis and related bone diseases.

I. Narita, Yumi Ito, F. Gejyo, 2006, Journal of bone and mineral metabolism.

Lifestyle Factors Associated with Undernutrition in Older People after the Great East Japan Earthquake: A Prospective Study in the Fukushima Health Management Survey

S. Yasumura, T. Ohira, J. Kazama, 2022, International journal of environmental research and public health.

Lenalidomide as a Beneficial Treatment Option for Renal Impairment Caused by Light Chain Deposition Disease

T. Ikezoe, K. Ikeda, T. Sano, 2018, Internal medicine.

Clinical and cardiac features of patients with subarachnoid haemorrhage presenting with out-of-hospital cardiac arrest.

M. Tomita, M. Kodama, Y. Aizawa, 2011, Resuscitation.

Effectiveness of calcimimetics on fractures in dialysis patients with secondary hyperparathyroidism: meta-analysis of randomized trials.

M. Fukagawa, Takuya Wakamatsu, J. Kazama, 2024, Journal of bone and mineral metabolism.

Ectopic ossification in the cranial dura mater in dialysis patients with secondary hyperparathyroidism

Y. Oyama, J. Kazama, I. Ezuka, 2009, NDT plus.